Corcept Therapeutics
CORT
#3439
Rank
NZ$6.97 B
Marketcap
NZ$66.20
Share price
-10.63%
Change (1 day)
-44.90%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): NZ$0.11 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are NZ$0.74 Billion. In 2024 the company made an earning of NZ$0.22 Billion, an increase over its 2023 earnings that were of NZ$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.11 B-50.64%
2024 NZ$0.22 B27.66%
2023 NZ$0.17 B-4.75%
2022 NZ$0.18 B-9.51%
2021 NZ$0.20 B-2.91%
2020 NZ$0.21 B14.87%
2019 NZ$0.18 B24.71%
2018 NZ$0.14 B69.32%
2017 NZ$87.76 M419.26%
2016 NZ$16.9 M-395.64%
2015 -NZ$5.72 Million-87.53%
2014 -NZ$45.87 Million-33.44%
2013 -NZ$68.9 Million
2011 -NZ$53.69 Million17.84%
2010 -NZ$45.56 Million35.5%
2009 -NZ$33.63 Million2.84%
2008 -NZ$32.7 Million60.81%
2007 -NZ$20.33 Million-52.14%
2006 -NZ$42.48 Million20.91%
2005 -NZ$35.14 Million31.87%
2004 -NZ$26.65 Million60.54%
2003 -NZ$16.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.79 B 49,305.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.26 B 24,939.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$19.67 B 17,974.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$37.36 B 34,218.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.33 B 35,113.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.33 B 12,150.66%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$51.11 M-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-NZ$45.57 Million-141.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.12 B 935.92%๐Ÿ‡บ๐Ÿ‡ธ USA